123 related articles for article (PubMed ID: 2933470)
1. The in vitro effect of retinol on human gingival epithelium. II. Modulation of Langerhans cell markers and interleukin-1 production.
Walsh LJ; Seymour GJ; Powell RN
J Invest Dermatol; 1985 Dec; 85(6):501-6. PubMed ID: 2933470
[TBL] [Abstract][Full Text] [Related]
2. Modulation of HLA-DR antigens in the gingival epithelium in vitro by heat-killed Fusobacterium nucleatum and E. coli lipopolysaccharide.
Walsh LJ; Seymour GJ; Bird PS; Powell RN
J Oral Pathol; 1985 Nov; 14(10):833-43. PubMed ID: 2414424
[TBL] [Abstract][Full Text] [Related]
3. Modulation of gingival Langerhans cell T6 antigen expression in vitro by interleukin 1 and an interleukin 1 inhibitor.
Walsh LJ; Seymour GJ; Powell RN
Clin Exp Immunol; 1986 May; 64(2):334-41. PubMed ID: 3091301
[TBL] [Abstract][Full Text] [Related]
4. Loss of Langerhans cells from gingival tissue maintained in organ culture.
Walsh LJ; Powell RN; Seymour GJ; Newcomb GM
J Oral Pathol; 1984 Dec; 13(6):604-13. PubMed ID: 6151591
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical analysis of effects of cyclosporin A on gingival epithelium.
Niimi A; Tohnai I; Kaneda T; Takeuchi M; Nagura H
J Oral Pathol Med; 1990 Oct; 19(9):397-403. PubMed ID: 1702835
[TBL] [Abstract][Full Text] [Related]
6. Modulation of class II (DR and DQ) antigen expression on gingival Langerhans cells in vitro by gamma interferon and prostaglandin E2.
Walsh LJ; Seymour GJ; Powell RN
J Oral Pathol; 1986 Jul; 15(6):347-51. PubMed ID: 3093653
[TBL] [Abstract][Full Text] [Related]
7. Human gingival Langerhans cells stimulate allogeneic lymphocytes: requirement for MHC class II antigens.
Walsh LJ; Seymour GJ; Powell RN
J Periodontol; 1990 Jun; 61(6):328-33. PubMed ID: 2366140
[TBL] [Abstract][Full Text] [Related]
8. In vitro modulation of T6 expression on gingival Langerhans cells by interleukin-1 inhibitors and ETAF.
Walsh LJ; Lander PE; Seymour GJ; Powell RN
J Dent Res; 1987 Mar; 66(3):766-9. PubMed ID: 3112200
[TBL] [Abstract][Full Text] [Related]
9. Loss of allogeneic T-cell activating ability and Langerhans cell markers in human epidermal cell cultures.
Demidem A; Faure M; Dezutter-Dambuyant C; Thivolet J
Clin Immunol Immunopathol; 1986 Mar; 38(3):319-26. PubMed ID: 2935342
[TBL] [Abstract][Full Text] [Related]
10. Oral mucosal Langerhans cells express DR and DQ antigens.
Walsh LJ; Seymour GJ; Savage NW
J Dent Res; 1986 Mar; 65(3):390-3. PubMed ID: 3457041
[TBL] [Abstract][Full Text] [Related]
11. The regulation of Langerhans cell T6, DR and DQ antigen expression: an hypothesis.
Walsh LJ; Seymour GJ; Powell RN
J Oral Pathol; 1988 Jan; 17(1):43-6. PubMed ID: 3131509
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of Class II (DR & DQ) antigens by human gingival Langerhans' cells and keratinocytes in vitro.
Walsh LJ; Seymour GJ; Powell RN
J Oral Pathol; 1987 Jan; 16(1):27-30. PubMed ID: 2435875
[TBL] [Abstract][Full Text] [Related]
13. Modulation of CD4 antigen expression on human gingival Langerhans cells by gamma interferon.
Walsh LJ; Parry A; Scholes A; Seymour GJ
Clin Exp Immunol; 1987 Nov; 70(2):379-85. PubMed ID: 3123106
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-10 inhibits the primary allogeneic T cell response to human epidermal Langerhans cells.
Péguet-Navarro J; Moulon C; Caux C; Dalbiez-Gauthier C; Banchereau J; Schmitt D
Eur J Immunol; 1994 Apr; 24(4):884-91. PubMed ID: 8149959
[TBL] [Abstract][Full Text] [Related]
15. OKT6 is not superior to HLA-DR or ATPase as a marker for Langerhans' cells in normal human epidermis.
Liu HH; Schroeter AL; Muller SA
Clin Exp Dermatol; 1986 May; 11(3):229-37. PubMed ID: 2943537
[No Abstract] [Full Text] [Related]
16. Langerhans cell dynamics in human gingiva during experimentally induced inflammation.
Moughal NA; Adonogianaki E; Kinane DF
J Biol Buccale; 1992 Sep; 20(3):163-7. PubMed ID: 1283608
[TBL] [Abstract][Full Text] [Related]
17. Retinoic acid upregulates human Langerhans cell antigen presentation and surface expression of HLA-DR and CD11c, a beta 2 integrin critically involved in T-cell activation.
Meunier L; Bohjanen K; Voorhees JJ; Cooper KD
J Invest Dermatol; 1994 Dec; 103(6):775-9. PubMed ID: 7798614
[TBL] [Abstract][Full Text] [Related]
18. Human epidermal Langerhans cells and peripheral blood monocytes. Accessory cell function, autoactivating and alloactivating capacity and ETAF/IL-1 production.
Räsänen L; Lehto M; Jansén C; Reunala T; Leinikki P
Scand J Immunol; 1986 Nov; 24(5):503-8. PubMed ID: 3491421
[TBL] [Abstract][Full Text] [Related]
19. Effect of X-irradiation on epidermal immune function: decreased density and alloantigen-presenting capacity of Ia+ Langerhans cells and impaired production of epidermal cell-derived thymocyte activating factor (ETAF).
Breathnach SM; Katz SI
J Invest Dermatol; 1985 Dec; 85(6):553-8. PubMed ID: 3877770
[TBL] [Abstract][Full Text] [Related]
20. Ontogeny of Langerhans cells in human embryonic and fetal skin: expression of HLA-DR and OKT-6 determinants.
Foster CA; Holbrook KA; Farr AG
J Invest Dermatol; 1986 Mar; 86(3):240-3. PubMed ID: 2427603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
